US Health Agencies Put Johnson & Johnson Vaccinations on Hold
Out of “an abundance of caution”, US health agencies have paused Johnson and Johnson vaccinations because of extremely rare blood clots possibly linked to this specific vaccine. So far, 6 cases have been identified out of more than 7 million people who got the J&J vaccine. That’s a rate of less than one in a million. For context, the risk of blood clots for COVID patients is 1 in 5. The risk of blood clots, albeit a different type of blood clot, from oral contraceptives is between 1 in 1,000 and 1 in 3,000. Overall, top health officials stress that the benefit of J&J’s COVID-19 vaccine far outweigh the risks.